| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,817 | 35,318 | 49,746 | 321,875 | | Cost of Revenue | (5,950) | 2,653 | 3,297 | 10,785 | | | Gross Profit | 21,767 | 32,665 | 46,449 | 311,090 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| (24,368) | | Selling General and Administrative | 10,936 | 52,582 | 74,544 | 118,543 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| 3,983 |
-
| 471,714 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,814 | (23,900) | (28,095) | (254,799) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (132,573) | (9,780) | 132,314 | 43,012 | | Earnings Before Interest And Taxes | 46,332 | (33,680) | 104,219 | (211,787) | | Interest Expense | 310 | 3,346 |
-
| 85,208 | | Income Before Tax | 46,022 | (37,026) | 104,219 | (296,995) | | Income Tax Expense | 3,585 | (310) | 9,555 | 27,311 | | Minority Interest |
-
|
-
|
-
| 55,814 | | | | Net Income From Continuing Ops | 53,896 | (36,716) | 94,664 | (268,492) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 53,896 | (36,716) | 94,664 | (268,492) | | Preferred Stock And Other Adjustments | (11,459) | 4,559 | 6,900 |
-
| | | Net Income Applicable To Common Shares | $42,437 | ($32,157) | $101,564 | ($268,492) |
|
0.42% Nasdaq 
Income Statement
